NVDA vs. CPH.TO
NVDA (NVIDIA Corporation) and CPH.TO (Cipher Pharmaceuticals Inc.) are both stocks. NVDA operates in Semiconductors (Technology), while CPH.TO operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, NVDA returned 68.47%/yr vs 7.91%/yr for CPH.TO. At a 0.10 correlation, their price movements are largely independent.
Performance
NVDA vs. CPH.TO - Performance Comparison
Loading charts...
Different Trading Currencies
NVDA is traded in USD, while CPH.TO is traded in CAD. To make them comparable, the CPH.TO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, NVDA achieves a 12.01% return, which is significantly higher than CPH.TO's 10.08% return. Over the past 10 years, NVDA has outperformed CPH.TO with an annualized return of 68.47%, while CPH.TO has yielded a comparatively lower 7.91% annualized return.
NVDA
- 1D
- 1.73%
- 1M
- -2.94%
- YTD
- 12.01%
- 6M
- 12.58%
- 1Y
- 47.43%
- 3Y*
- 75.35%
- 5Y*
- 64.54%
- 10Y*
- 68.47%
CPH.TO
- 1D
- -0.04%
- 1M
- -16.23%
- YTD
- 10.08%
- 6M
- 14.24%
- 1Y
- 24.86%
- 3Y*
- 62.35%
- 5Y*
- 56.53%
- 10Y*
- 7.91%
NVDA vs. CPH.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NVDA NVIDIA Corporation | 12.01% | 38.92% | 171.25% | 239.02% | -50.26% | 125.48% | 122.30% | 76.94% | -30.82% | 81.99% |
CPH.TO Cipher Pharmaceuticals Inc. | 10.08% | 10.20% | 138.31% | 47.79% | 104.02% | 90.42% | -36.49% | -8.51% | -67.81% | 7.26% |
Correlation
The correlation between NVDA and CPH.TO is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Jul 5, 2006 | 0.10 |
Fundamentals
NVDA:
$5.09T
CPH.TO:
CA$435.58M
NVDA:
$6.53
CPH.TO:
CA$1.19
NVDA:
31.97
CPH.TO:
14.22
NVDA:
0.18
CPH.TO:
0.17
NVDA:
20.13
CPH.TO:
8.65
NVDA:
26.03
CPH.TO:
3.28
NVDA:
$253.49B
CPH.TO:
CA$50.92M
NVDA:
$187.95B
CPH.TO:
CA$37.95M
NVDA:
$192.76B
CPH.TO:
CA$25.12M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVDA vs. CPH.TO — Risk / Return Rank
NVDA
CPH.TO
NVDA vs. CPH.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for NVIDIA Corporation (NVDA) and Cipher Pharmaceuticals Inc. (CPH.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NVDA | CPH.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.78 | ||
| Sortino ratioReturn per unit of downside risk | +0.64 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.15 | +0.09 |
| Calmar ratioReturn relative to maximum drawdown | 2.36 | 1.03 | +1.33 |
| Martin ratioReturn relative to average drawdown | 5.73 | 2.22 | +3.51 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NVDA | CPH.TO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.37 | 0.59 | +0.78 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.25 | 1.14 | +0.12 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 1.38 | 0.13 | +1.25 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.63 | 0.07 | +0.55 |
Drawdowns
NVDA vs. CPH.TO - Drawdown Comparison
The maximum NVDA drawdown since its inception was -89.72%, smaller than the maximum CPH.TO drawdown of -98.29%. Use the drawdown chart below to compare losses from any high point for NVDA and CPH.TO.
Loading charts...
Drawdown Indicators
| NVDA | CPH.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.72% | -98.29% | +8.57% |
Max Drawdown (1Y)Largest decline over 1 year | -20.21% | -24.22% | +4.01% |
Max Drawdown (3Y)Largest decline over 3 years | -36.88% | -46.02% | +9.14% |
Max Drawdown (5Y)Largest decline over 5 years | -66.34% | -46.02% | -20.32% |
Max Drawdown (10Y)Largest decline over 10 years | -66.34% | -95.16% | +28.82% |
Current DrawdownCurrent decline from peak | -11.39% | -24.23% | +12.84% |
Average DrawdownAverage peak-to-trough decline | -36.20% | -65.74% | +29.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.30% | 11.22% | -2.92% |
Volatility
NVDA vs. CPH.TO - Volatility Comparison
The current volatility for NVIDIA Corporation (NVDA) is 13.14%, while Cipher Pharmaceuticals Inc. (CPH.TO) has a volatility of 13.93%. This indicates that NVDA experiences smaller price fluctuations and is considered to be less risky than CPH.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVDA | CPH.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.14% | 13.93% | -0.79% |
Volatility (6M)Calculated over the trailing 6-month period | 26.37% | 28.17% | -1.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 34.81% | 42.14% | -7.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 51.75% | 49.98% | +1.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.85% | 61.43% | -11.58% |
Dividends
NVDA vs. CPH.TO - Dividend Comparison
NVDA's dividend yield for the trailing twelve months is around 0.14%, while CPH.TO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CPH.TO Cipher Pharmaceuticals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.14% | 0.02% | 0.03% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% |
Financials
NVDA vs. CPH.TO - Financials Comparison
This section allows you to compare key financial metrics between NVIDIA Corporation and Cipher Pharmaceuticals Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NVDA vs. CPH.TO - Profitability Comparison
NVDA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported a gross profit of 61.16B and revenue of 81.62B. Therefore, the gross margin over that period was 74.9%.
CPH.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cipher Pharmaceuticals Inc. reported a gross profit of 8.35M and revenue of 12.30M. Therefore, the gross margin over that period was 67.9%.
NVDA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported an operating income of 53.54B and revenue of 81.62B, resulting in an operating margin of 65.6%.
CPH.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cipher Pharmaceuticals Inc. reported an operating income of 5.50M and revenue of 12.30M, resulting in an operating margin of 44.7%.
NVDA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported a net income of 58.32B and revenue of 81.62B, resulting in a net margin of 71.5%.
CPH.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cipher Pharmaceuticals Inc. reported a net income of 6.06M and revenue of 12.30M, resulting in a net margin of 49.3%.
Frequently Asked Questions
NVDA and CPH.TO have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for NVDA and CPH.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer